BACKGROUND Anterior cervical discectomy and fusion (ACDF) is a commonly performed and effective procedure for treating cervical spondylosis. Although cerebrospinal fluid (CSF) leakage is an uncommon complication, occurring in 0.2% to 1.7% of cases, it typically presents as an extraspinal leak. This report describes the case of a 51-year-old woman with postoperative headache due to an early epidural (intraspinal) CSF leak following ACDF - a complication that has not been previously reported. CASE REPORT A 51-year-old woman presented with chronic neck pain, cervicogenic headaches, and upper-limb paresthesia due to multilevel cervical spondylosis. MRI revealed discopathy at C4-C7. She underwent elective ACDF at C4-C7. During discectomy at C5/C6, a CSF leak was observed before exposure of the posterior longitudinal ligament (PLL) and was repaired intraoperatively using TachoSil, a muscle graft, and fibrin glue. On the first postoperative day, the patient developed headaches, nausea, and dizziness consistent with intracranial hypotension. MRI on postoperative day 4 revealed a ventral epidural CSF collection. Lumbar drainage was placed, resulting in resolution of symptoms and the CSF collection. Follow-up MRI at 6 weeks confirmed complete recovery. CONCLUSIONS This report presents a rare case of early epidural CSF leak following ACDF. Prompt recognition and conservative management with lumbar drainage resulted in full recovery without reoperation. Awareness of this potential complication can aid early diagnosis and prevent unnecessary surgical interventions.
{"title":"Early Epidural Cerebrospinal Fluid Leak After Anterior Cervical Discectomy and Fusion: A Case Report of Postoperative Intracranial Hypotension.","authors":"Bartosz Limanówka, Leszek Sagan","doi":"10.12659/AJCR.950550","DOIUrl":"10.12659/AJCR.950550","url":null,"abstract":"<p><p>BACKGROUND Anterior cervical discectomy and fusion (ACDF) is a commonly performed and effective procedure for treating cervical spondylosis. Although cerebrospinal fluid (CSF) leakage is an uncommon complication, occurring in 0.2% to 1.7% of cases, it typically presents as an extraspinal leak. This report describes the case of a 51-year-old woman with postoperative headache due to an early epidural (intraspinal) CSF leak following ACDF - a complication that has not been previously reported. CASE REPORT A 51-year-old woman presented with chronic neck pain, cervicogenic headaches, and upper-limb paresthesia due to multilevel cervical spondylosis. MRI revealed discopathy at C4-C7. She underwent elective ACDF at C4-C7. During discectomy at C5/C6, a CSF leak was observed before exposure of the posterior longitudinal ligament (PLL) and was repaired intraoperatively using TachoSil, a muscle graft, and fibrin glue. On the first postoperative day, the patient developed headaches, nausea, and dizziness consistent with intracranial hypotension. MRI on postoperative day 4 revealed a ventral epidural CSF collection. Lumbar drainage was placed, resulting in resolution of symptoms and the CSF collection. Follow-up MRI at 6 weeks confirmed complete recovery. CONCLUSIONS This report presents a rare case of early epidural CSF leak following ACDF. Prompt recognition and conservative management with lumbar drainage resulted in full recovery without reoperation. Awareness of this potential complication can aid early diagnosis and prevent unnecessary surgical interventions.</p>","PeriodicalId":39064,"journal":{"name":"American Journal of Case Reports","volume":"27 ","pages":"e950550"},"PeriodicalIF":0.7,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12822608/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145967434","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Gurpreet Singh, Jack Petroski, Drake Marden, Andrew Knauer
BACKGROUND Gallbladder agenesis is a rare congenital anomaly resulting from failed cystic bud development or canalization during early embryogenesis. While frequently asymptomatic, up to half of patients develop postprandial right upper-quadrant pain resembling biliary colic. This report describes an unusual case of gallbladder agenesis in a 38-year-old man with Klinefelter syndrome who presented with hematemesis and right upper-quadrant pain. CASE REPORT A 38-year-old man with known Klinefelter syndrome (47, XXY) and no prior abdominal surgery presented with hematemesis, lightheadedness, syncope, and right upper-quadrant pain. Laboratory testing revealed mild transaminitis, elevated ferritin, and normal bilirubin. Computed tomography angiography initially revealed hepatic steatosis and splenomegaly, and no gallbladder was visualized on hepatobiliary iminodiacetic acid scan and ultrasound. Esophagogastroduodenoscopy showed mild antral gastritis and a small hiatal hernia without active bleeding. Gallbladder agenesis was confirmed by magnetic resonance cholangiopancreatography. The patient's hematemesis resolved spontaneously, and he was discharged in stable condition with hepatology follow-up. CONCLUSIONS This case highlights the diagnostic value of MRCP in confirming gallbladder agenesis and avoiding unnecessary surgical exploration. Hematemesis as the initial presentation is highly atypical, suggesting a potential but unproven link between gallbladder agenesis and upper-gastrointestinal bleeding. Additionally, this report presents the first known coexistence of GA and Klinefelter syndrome, raising the possibility of a subtle developmental correlation between chromosomal nondisjunction and endodermal organogenesis. Recognition of such rare presentations expands the phenotypic spectrum of Klinefelter-associated hepatobiliary abnormalities and underscores the need for awareness of gallbladder agenesis in patients with biliary-type pain but no visible gallbladder on imaging.
{"title":"Gallbladder Agenesis in a Patient With Klinefelter Syndrome Presenting With Hematemesis and Right Upper-Quadrant Pain.","authors":"Gurpreet Singh, Jack Petroski, Drake Marden, Andrew Knauer","doi":"10.12659/AJCR.949945","DOIUrl":"10.12659/AJCR.949945","url":null,"abstract":"<p><p>BACKGROUND Gallbladder agenesis is a rare congenital anomaly resulting from failed cystic bud development or canalization during early embryogenesis. While frequently asymptomatic, up to half of patients develop postprandial right upper-quadrant pain resembling biliary colic. This report describes an unusual case of gallbladder agenesis in a 38-year-old man with Klinefelter syndrome who presented with hematemesis and right upper-quadrant pain. CASE REPORT A 38-year-old man with known Klinefelter syndrome (47, XXY) and no prior abdominal surgery presented with hematemesis, lightheadedness, syncope, and right upper-quadrant pain. Laboratory testing revealed mild transaminitis, elevated ferritin, and normal bilirubin. Computed tomography angiography initially revealed hepatic steatosis and splenomegaly, and no gallbladder was visualized on hepatobiliary iminodiacetic acid scan and ultrasound. Esophagogastroduodenoscopy showed mild antral gastritis and a small hiatal hernia without active bleeding. Gallbladder agenesis was confirmed by magnetic resonance cholangiopancreatography. The patient's hematemesis resolved spontaneously, and he was discharged in stable condition with hepatology follow-up. CONCLUSIONS This case highlights the diagnostic value of MRCP in confirming gallbladder agenesis and avoiding unnecessary surgical exploration. Hematemesis as the initial presentation is highly atypical, suggesting a potential but unproven link between gallbladder agenesis and upper-gastrointestinal bleeding. Additionally, this report presents the first known coexistence of GA and Klinefelter syndrome, raising the possibility of a subtle developmental correlation between chromosomal nondisjunction and endodermal organogenesis. Recognition of such rare presentations expands the phenotypic spectrum of Klinefelter-associated hepatobiliary abnormalities and underscores the need for awareness of gallbladder agenesis in patients with biliary-type pain but no visible gallbladder on imaging.</p>","PeriodicalId":39064,"journal":{"name":"American Journal of Case Reports","volume":"27 ","pages":"e949945"},"PeriodicalIF":0.7,"publicationDate":"2026-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12817595/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145960552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
YeSheng Zhang, XiaoXin Gu, YiHeng Yang, GuoChao Ye, Neng Lou
BACKGROUND Herniation of the bowel through the obturator foramen is a rare cause of intestinal obstruction. It occurs more frequently in elderly, thin women and typically presents on the right side. Because of its deep pelvic location, diagnosis is often delayed, and emergency surgery is usually required. When reduction is difficult, alternative approaches, such as the double-incision technique, can facilitate safe and effective management. This report presents the case of a 67-year-old woman with acute right lower abdominal pain due to an incarcerated obturator hernia, managed with a double-incision approach, segmental bowel resection, and entero-enterostomy. CASE REPORT A 67-year-old woman presented with acute right lower abdominal pain and symptoms of intestinal obstruction. Abdominal computed tomography (CT) revealed an incarcerated obturator hernia. Emergency surgery was performed through a lower midline incision, but reduction of the herniated bowel was unsuccessful due to severe edema and tight incarceration. A secondary groin incision was made to access the obturator canal directly. The necrotic bowel segment was resected, and an entero-enterostomy was performed. The patient recovered uneventfully and was discharged on postoperative day 10. CONCLUSIONS This case highlights the importance of prompt diagnosis and emergency surgical treatment of incarcerated obturator hernia to prevent bowel ischemia, necrosis, and potentially fatal complications. A combined approach using an additional groin incision allowed for safe management, including decompression, adhesiolysis, and resection of the necrotic bowel. This approach enables safe decompression, adhesiolysis, and resection, thereby minimizing intraoperative risk and improving postoperative outcomes in complex cases.
{"title":"Double-Incision Surgical Management of Incarcerated Obturator Hernia Presenting With Acute Right Lower Abdominal Pain in a 67-Year-Old Woman.","authors":"YeSheng Zhang, XiaoXin Gu, YiHeng Yang, GuoChao Ye, Neng Lou","doi":"10.12659/AJCR.949940","DOIUrl":"10.12659/AJCR.949940","url":null,"abstract":"<p><p>BACKGROUND Herniation of the bowel through the obturator foramen is a rare cause of intestinal obstruction. It occurs more frequently in elderly, thin women and typically presents on the right side. Because of its deep pelvic location, diagnosis is often delayed, and emergency surgery is usually required. When reduction is difficult, alternative approaches, such as the double-incision technique, can facilitate safe and effective management. This report presents the case of a 67-year-old woman with acute right lower abdominal pain due to an incarcerated obturator hernia, managed with a double-incision approach, segmental bowel resection, and entero-enterostomy. CASE REPORT A 67-year-old woman presented with acute right lower abdominal pain and symptoms of intestinal obstruction. Abdominal computed tomography (CT) revealed an incarcerated obturator hernia. Emergency surgery was performed through a lower midline incision, but reduction of the herniated bowel was unsuccessful due to severe edema and tight incarceration. A secondary groin incision was made to access the obturator canal directly. The necrotic bowel segment was resected, and an entero-enterostomy was performed. The patient recovered uneventfully and was discharged on postoperative day 10. CONCLUSIONS This case highlights the importance of prompt diagnosis and emergency surgical treatment of incarcerated obturator hernia to prevent bowel ischemia, necrosis, and potentially fatal complications. A combined approach using an additional groin incision allowed for safe management, including decompression, adhesiolysis, and resection of the necrotic bowel. This approach enables safe decompression, adhesiolysis, and resection, thereby minimizing intraoperative risk and improving postoperative outcomes in complex cases.</p>","PeriodicalId":39064,"journal":{"name":"American Journal of Case Reports","volume":"27 ","pages":"e949940"},"PeriodicalIF":0.7,"publicationDate":"2026-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12817597/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145967403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Paulo Reis Rizzo Esselin de Melo, Victor Ramos Mussa Dib, Carlos Augusto Scussel Madalosso, Luiz Alfredo Vieira d'Almeida, Eudes Paiva de Godoy, Elinton Adami Chaim, Caio Gustavo Gaspar de Aquino, Rui José Silva Ribeiro, Carlos Antonio Madalosso, Hiroji Okano Júnior, Giorgio Alfredo Pedroso Baretta, Nicholas Tavares Kruel, Joe Joaquim Waltrick Junior, Diogo Swain Kfouri, Félix Antônio Insaurriaga Dos Santos, Nilton Tokio Kawahara, Rafael Antoniazzi Abaid, Fernando de Barros, Carlos Frota Dillenburg, José Geraldo Moraes Sampaio Neto, Ricardo Augusto Martins Bueno da Costa, Guilherme Spósito Ribeiro Goyano, Fernando Reis Esselin Melo, Thonya Cruz Braga, Daniel Oscar Caiña, Patrick Noel, Tahir Ebrahim Yunus, Chetan Parmar, Ricardo Zorron, André Teixeira, Manoel Galvao Neto, Almino Cardoso Ramos, Antônio Torres
BACKGROUND Metabolic and bariatric surgeries (MBS) are effective treatments for obesity and related comorbidities, such as diabetes and hypertension. In patients with morbid obesity and challenges like hepatomegaly, conventional procedures may increase risks. Staged MBS was developed to address these issues, enhancing safety. This report highlights the successful use of isolated intestinal transit bipartition with duodeno-ileal anastomosis, preserving the duodenum, as the first stage of the duodenal switch. CASE REPORT A 40-year-old woman with a BMI of 40.2 kg/m² was booked for MBS. Severe hepatomegaly impaired safe access to the esophagogastric junction, leading to the performance of only the intestinal stage of the duodenal switch. A duodeno-ileal anastomosis was created 250 cm from the ileocecal valve, preserving the stomach and partial duodenal function. Without the gastric stage, the patient achieved 50 kg of weight loss (equivalent to 78.7% excess weight loss) over 19 years, without requiring additional surgery. Minor complications included occasional diarrhea, meteorism, and difficulties with vitamin supplementation, all managed effectively through dietary adjustments and nutritional guidance. A benefit was increased satiety. CONCLUSIONS Isolated intestinal transit bipartition with duodeno-ileal anastomosis is an approach that may be used in exceptional cases, such as with this patient. Despite the favorable long-term follow-up results, further studies are necessary to better understand this approach. This method demonstrated sustained weight loss and long-term metabolic control, potentially representing a promising initial treatment option for patients with lower BMIs, including those with type 2 diabetes.
{"title":"Long-Term Outcome of Isolated Duodenal Transit Bipartition as Initial Metabolic Surgery: A 19-Year Follow-Up Case Report.","authors":"Paulo Reis Rizzo Esselin de Melo, Victor Ramos Mussa Dib, Carlos Augusto Scussel Madalosso, Luiz Alfredo Vieira d'Almeida, Eudes Paiva de Godoy, Elinton Adami Chaim, Caio Gustavo Gaspar de Aquino, Rui José Silva Ribeiro, Carlos Antonio Madalosso, Hiroji Okano Júnior, Giorgio Alfredo Pedroso Baretta, Nicholas Tavares Kruel, Joe Joaquim Waltrick Junior, Diogo Swain Kfouri, Félix Antônio Insaurriaga Dos Santos, Nilton Tokio Kawahara, Rafael Antoniazzi Abaid, Fernando de Barros, Carlos Frota Dillenburg, José Geraldo Moraes Sampaio Neto, Ricardo Augusto Martins Bueno da Costa, Guilherme Spósito Ribeiro Goyano, Fernando Reis Esselin Melo, Thonya Cruz Braga, Daniel Oscar Caiña, Patrick Noel, Tahir Ebrahim Yunus, Chetan Parmar, Ricardo Zorron, André Teixeira, Manoel Galvao Neto, Almino Cardoso Ramos, Antônio Torres","doi":"10.12659/AJCR.950650","DOIUrl":"10.12659/AJCR.950650","url":null,"abstract":"<p><p>BACKGROUND Metabolic and bariatric surgeries (MBS) are effective treatments for obesity and related comorbidities, such as diabetes and hypertension. In patients with morbid obesity and challenges like hepatomegaly, conventional procedures may increase risks. Staged MBS was developed to address these issues, enhancing safety. This report highlights the successful use of isolated intestinal transit bipartition with duodeno-ileal anastomosis, preserving the duodenum, as the first stage of the duodenal switch. CASE REPORT A 40-year-old woman with a BMI of 40.2 kg/m² was booked for MBS. Severe hepatomegaly impaired safe access to the esophagogastric junction, leading to the performance of only the intestinal stage of the duodenal switch. A duodeno-ileal anastomosis was created 250 cm from the ileocecal valve, preserving the stomach and partial duodenal function. Without the gastric stage, the patient achieved 50 kg of weight loss (equivalent to 78.7% excess weight loss) over 19 years, without requiring additional surgery. Minor complications included occasional diarrhea, meteorism, and difficulties with vitamin supplementation, all managed effectively through dietary adjustments and nutritional guidance. A benefit was increased satiety. CONCLUSIONS Isolated intestinal transit bipartition with duodeno-ileal anastomosis is an approach that may be used in exceptional cases, such as with this patient. Despite the favorable long-term follow-up results, further studies are necessary to better understand this approach. This method demonstrated sustained weight loss and long-term metabolic control, potentially representing a promising initial treatment option for patients with lower BMIs, including those with type 2 diabetes.</p>","PeriodicalId":39064,"journal":{"name":"American Journal of Case Reports","volume":"27 ","pages":"e950650"},"PeriodicalIF":0.7,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12817596/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145953313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BACKGROUND Appendicitis is a common surgical emergency, but the diagnosis may remain unclear and challenging, particularly in middle-aged women who present with atypical features. Atypical appendicitis, defined as appendiceal inflammation without classic migratory pain, nausea, or fever; it often mimics gynecological disorders, contributing to diagnostic delays. The present case is unique because it involved an unusually prolonged 2-month history of persistent suprapubic pain before acute exacerbation. Such a chronic course preceding the acute phase is uncommon and further complicated the diagnostic process, underscoring the need for clinical vigilance in prolonged, unexplained lower abdominal pain. CASE REPORT A 46-year-old woman presented with a 2-month history of persistent suprapubic pain without associated systemic symptoms. Her gynecological history included prolonged intrauterine copper device use and recent postcoital bleeding. Initial clinical evaluation suggested pelvic inflammatory disease, and empirical antibiotics provided minimal symptomatic relief. Laboratory investigations and imaging, including pelvic ultrasound and computed tomography, were inconclusive, demonstrating bilateral simple ovarian cysts and a minimally distended appendix with mild periappendiceal fat stranding. Due to worsening localized right lower abdominal pain and persistent symptoms, laparoscopic appendectomy was performed. Histopathology confirmed early acute appendicitis. The patient's postoperative recovery was uneventful. CONCLUSIONS This case underscores the need to maintain high clinical suspicion for appendicitis despite normal white blood cell counts and equivocal imaging, thereby supporting re-evaluation protocols for persistent abdominal pain.
{"title":"Atypical Appendicitis Mimicking Gynecological Pathology: A Diagnostic Challenge in a Middle-Aged Woman.","authors":"Uma Hemant Chourasia","doi":"10.12659/AJCR.949850","DOIUrl":"10.12659/AJCR.949850","url":null,"abstract":"<p><p>BACKGROUND Appendicitis is a common surgical emergency, but the diagnosis may remain unclear and challenging, particularly in middle-aged women who present with atypical features. Atypical appendicitis, defined as appendiceal inflammation without classic migratory pain, nausea, or fever; it often mimics gynecological disorders, contributing to diagnostic delays. The present case is unique because it involved an unusually prolonged 2-month history of persistent suprapubic pain before acute exacerbation. Such a chronic course preceding the acute phase is uncommon and further complicated the diagnostic process, underscoring the need for clinical vigilance in prolonged, unexplained lower abdominal pain. CASE REPORT A 46-year-old woman presented with a 2-month history of persistent suprapubic pain without associated systemic symptoms. Her gynecological history included prolonged intrauterine copper device use and recent postcoital bleeding. Initial clinical evaluation suggested pelvic inflammatory disease, and empirical antibiotics provided minimal symptomatic relief. Laboratory investigations and imaging, including pelvic ultrasound and computed tomography, were inconclusive, demonstrating bilateral simple ovarian cysts and a minimally distended appendix with mild periappendiceal fat stranding. Due to worsening localized right lower abdominal pain and persistent symptoms, laparoscopic appendectomy was performed. Histopathology confirmed early acute appendicitis. The patient's postoperative recovery was uneventful. CONCLUSIONS This case underscores the need to maintain high clinical suspicion for appendicitis despite normal white blood cell counts and equivocal imaging, thereby supporting re-evaluation protocols for persistent abdominal pain.</p>","PeriodicalId":39064,"journal":{"name":"American Journal of Case Reports","volume":"27 ","pages":"e949850"},"PeriodicalIF":0.7,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12817603/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145960595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BACKGROUND Uterine fibroids are common benign gynecologic tumors characterized by abnormal uterine bleeding, menorrhagia, and anemia. Myomatous erythrocytosis syndrome (MES), a rare secondary erythrocytosis associated with fibroids, presumably results from ectopic erythropoietin production by the fibroids, which activates the Janus kinase 2 (JAK-2) pathway and increases red blood cell counts. MES clinically presents with abdominal distension, skin discoloration, and menstrual irregularities. Management is complex due to substantial risks of intraoperative bleeding and thromboembolism. This report describes a 33-year-old woman with MES. After myomectomy, her erythrocytosis normalized, but she developed postoperative bleeding. CASE REPORT A 33-year-old woman presented with a 2-year history of progressive abdominal distension and an abdominal mass comparable in size to a 20-week gravid uterus, plethoric facies, and reddish-purple nail beds. Her hemoglobin level was 19.7 g/dL; hematocrit was 60.4%. Ultrasound and computed tomography confirmed a 25×20×12 cm fibromatous uterus. To reduce thromboembolic risk, she received low-molecular-weight heparin and intravenous hydration preoperatively. Abdominal myomectomy was performed, during which substantially increased uterine and fibroid vascularity was observed. However, the patient experienced severe postoperative hemorrhage (1800 mL/24 h), warranting a second operation for hemostasis. She recovered well and was discharged on postoperative day 14; her hemoglobin level normalized. Pathologic examination confirmed uterine leiomyoma, supporting the diagnosis of MES. CONCLUSIONS MES is a rare condition characterized by large uterine fibroids and erythrocytosis; postoperative bleeding and thrombosis are common complications. This case highlights the importance of accurate diagnosis and effective management. Erythropoietin-related therapeutic targets for MES are needed.
{"title":"Giant Uterine Fibroid Complicated by Abnormal Erythrocytosis in a 33-Year-Old Woman: A Case Report.","authors":"Xia Nong, Hu Li, Yuxia Wang","doi":"10.12659/AJCR.950288","DOIUrl":"10.12659/AJCR.950288","url":null,"abstract":"<p><p>BACKGROUND Uterine fibroids are common benign gynecologic tumors characterized by abnormal uterine bleeding, menorrhagia, and anemia. Myomatous erythrocytosis syndrome (MES), a rare secondary erythrocytosis associated with fibroids, presumably results from ectopic erythropoietin production by the fibroids, which activates the Janus kinase 2 (JAK-2) pathway and increases red blood cell counts. MES clinically presents with abdominal distension, skin discoloration, and menstrual irregularities. Management is complex due to substantial risks of intraoperative bleeding and thromboembolism. This report describes a 33-year-old woman with MES. After myomectomy, her erythrocytosis normalized, but she developed postoperative bleeding. CASE REPORT A 33-year-old woman presented with a 2-year history of progressive abdominal distension and an abdominal mass comparable in size to a 20-week gravid uterus, plethoric facies, and reddish-purple nail beds. Her hemoglobin level was 19.7 g/dL; hematocrit was 60.4%. Ultrasound and computed tomography confirmed a 25×20×12 cm fibromatous uterus. To reduce thromboembolic risk, she received low-molecular-weight heparin and intravenous hydration preoperatively. Abdominal myomectomy was performed, during which substantially increased uterine and fibroid vascularity was observed. However, the patient experienced severe postoperative hemorrhage (1800 mL/24 h), warranting a second operation for hemostasis. She recovered well and was discharged on postoperative day 14; her hemoglobin level normalized. Pathologic examination confirmed uterine leiomyoma, supporting the diagnosis of MES. CONCLUSIONS MES is a rare condition characterized by large uterine fibroids and erythrocytosis; postoperative bleeding and thrombosis are common complications. This case highlights the importance of accurate diagnosis and effective management. Erythropoietin-related therapeutic targets for MES are needed.</p>","PeriodicalId":39064,"journal":{"name":"American Journal of Case Reports","volume":"27 ","pages":"e950288"},"PeriodicalIF":0.7,"publicationDate":"2026-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12817613/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145953237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Adam Henderson, Mohamed G Ibrahim, Mario El Hayek, Margaret E McKinney, Jesse W St Clair Iv
BACKGROUND Endovascular aneurysm repair (EVAR) effectively treats abdominal aortic aneurysms but risks complications, including endoleak and graft infection. CASE REPORT A 74-year-old man with EVAR, complicated by endoleak the following month with persistent pain following endoleak repair, presented with multiple abscesses (epidural, psoas, and disc space) and an aorto-disc fistula 7 months after the endoleak repair. Long-term corticosteroid use and an interleukin-6 inhibitor for presumed polymyalgia rheumatica contributed to immunosuppression. This misdiagnosis, along with immunosuppression and inconclusive outside imaging, diagnostic tunneling contributed to a delayed diagnosis until discitis, osteomyelitis, and abscesses were discovered on computed tomography (CT). This case is a rare presentation, and there is scant literature on spinal abscess from EVAR. Given the uniqueness and complexity of the presentation, a multidisciplinary approach was required for a better outcome, including multiple surgery teams and multiple medical teams. Management included abscess drainage, EVAR explant with rifampin-soaked Dacron graft reconstruction, surgical debridement, antibiotic beads, and 6 weeks of intravenous daptomycin for coverage of previously positive spinal tissue cultures (methicillin-sensitive Staphylococcus aureus and Cutibacterium acnes) with a plan for lifelong suppression with doxycycline. The patient ultimately had a new endoleak requiring repair, but was doing well as of his last appointment 8 months after his presentation to our facility. CONCLUSIONS This case demonstrates the need for postoperative vigilance and multidisciplinary care for patients undergoing EVAR. Comprehensive source control and close follow-up have thus far yielded a successful clinical outcome.
{"title":"Complex Aorto-Spinal Fistula With Multifocal Abscesses in an Immunosuppressed Elderly Man Following Endovascular Aortic Repair.","authors":"Adam Henderson, Mohamed G Ibrahim, Mario El Hayek, Margaret E McKinney, Jesse W St Clair Iv","doi":"10.12659/AJCR.949903","DOIUrl":"10.12659/AJCR.949903","url":null,"abstract":"<p><p>BACKGROUND Endovascular aneurysm repair (EVAR) effectively treats abdominal aortic aneurysms but risks complications, including endoleak and graft infection. CASE REPORT A 74-year-old man with EVAR, complicated by endoleak the following month with persistent pain following endoleak repair, presented with multiple abscesses (epidural, psoas, and disc space) and an aorto-disc fistula 7 months after the endoleak repair. Long-term corticosteroid use and an interleukin-6 inhibitor for presumed polymyalgia rheumatica contributed to immunosuppression. This misdiagnosis, along with immunosuppression and inconclusive outside imaging, diagnostic tunneling contributed to a delayed diagnosis until discitis, osteomyelitis, and abscesses were discovered on computed tomography (CT). This case is a rare presentation, and there is scant literature on spinal abscess from EVAR. Given the uniqueness and complexity of the presentation, a multidisciplinary approach was required for a better outcome, including multiple surgery teams and multiple medical teams. Management included abscess drainage, EVAR explant with rifampin-soaked Dacron graft reconstruction, surgical debridement, antibiotic beads, and 6 weeks of intravenous daptomycin for coverage of previously positive spinal tissue cultures (methicillin-sensitive Staphylococcus aureus and Cutibacterium acnes) with a plan for lifelong suppression with doxycycline. The patient ultimately had a new endoleak requiring repair, but was doing well as of his last appointment 8 months after his presentation to our facility. CONCLUSIONS This case demonstrates the need for postoperative vigilance and multidisciplinary care for patients undergoing EVAR. Comprehensive source control and close follow-up have thus far yielded a successful clinical outcome.</p>","PeriodicalId":39064,"journal":{"name":"American Journal of Case Reports","volume":"27 ","pages":"e949903"},"PeriodicalIF":0.7,"publicationDate":"2026-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12817604/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145949405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BACKGROUND Persistent COVID-19 in immunocompromised patients, such as those with B-cell depletion or hematologic malignancies, is an important clinical challenge. Clinically, cases that do not respond to guideline-based antivirals, such as molnupiravir, remdesivir, and nirmatrelvir/ritonavir, are occasionally encountered, but effective therapeutic alternatives remain scarce. We report a case of persistent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection unresponsive to guideline-based antivirals, for which the traditional Japanese herbal medicine Mao-to (Ma-huang-tang) led to clinical improvement. CASE REPORT A 62-year-old man, who underwent treatment for follicular lymphoma with anti-cluster of differentiation-20 antibody and achieved remission, developed persistent SARS-CoV-2 infection. Despite 1 course of molnupiravir and nirmatrelvir/ritonavir each and multiple courses of remdesivir and corticosteroids each, SARS-CoV-2 infection persisted for over 2 months. Following these treatments, the SARS-CoV-2 polymerase chain reaction cycle threshold (Ct) value was 27.6, indicating active COVID-19. Given the lack of further treatment options and clinical stability, Mao-to (Ma-huang-tang), a Japanese herbal medicine ("Kampo"), was then administered as a commercially available extract granule (2.5 g, 3 times daily) for 14 days. The SARS-CoV-2 polymerase Ct value improved to 41, suggesting a marked reduction in viral load, with improved clinical symptoms. CONCLUSIONS Mao-to may offer a cost-effective adjunctive option for persistent COVID-19 in immunocompromised patients who fail to respond to conventional therapies. In addition, 14 days of Mao-to treatment cost approximately 1200 JPY (USD $8), significantly less than extended courses of standard antivirals. This case suggests the potential utility of traditional herbal medicine in managing persistent SARS-CoV-2 infections when conventional therapies fail.
背景免疫功能低下患者(如b细胞耗竭或血液系统恶性肿瘤患者)的持续COVID-19是一项重要的临床挑战。在临床上,偶尔会遇到对基于指南的抗病毒药物(如莫努皮拉韦、瑞德西韦和尼马特利韦/利托那韦)没有反应的病例,但有效的治疗方案仍然很少。我们报告一例持续的严重急性呼吸综合征冠状病毒2 (SARS-CoV-2)感染,对基于指南的抗病毒药物无反应,日本传统草药茅陀(马皇汤)导致临床改善。病例报告:一名62岁男性接受滤泡性淋巴瘤抗聚类分化-20抗体治疗并获得缓解后,出现了持续的SARS-CoV-2感染。尽管服用了1个疗程的莫诺匹拉韦和尼马特利韦/利托那韦,并服用了多个疗程的瑞德西韦和皮质类固醇,但SARS-CoV-2感染持续了2个多月。经这些治疗后,SARS-CoV-2聚合酶链反应周期阈值(Ct)为27.6,表明COVID-19活性。考虑到缺乏进一步的治疗选择和临床稳定性,然后以市售提取物颗粒(2.5 g,每日3次)的形式给予Mao-to (ma - huangtang),一种日本草药(“Kampo”),持续14天。SARS-CoV-2聚合酶Ct值改善至41,表明病毒载量明显下降,临床症状有所改善。结论:对于对常规治疗无效的免疫功能低下患者,Mao-to可能是一种具有成本效益的辅助选择。此外,14天的Mao-to治疗费用约为1200日元(8美元),明显低于标准抗病毒药物的延长疗程。这一病例表明,当传统疗法失败时,传统草药在治疗持续性SARS-CoV-2感染方面的潜在效用。
{"title":"Persistent SARS-CoV-2 Infection in an Immunocompromised Host Treated Successfully With the Japanese Herbal Medicine, Mao-to: A Case Report.","authors":"Takayuki Yamada, Shiro Sonoda, Mitsuki Otsuka, Tsuyoshi Shirai, Tomoya Tateishi, Haruhiko Furusawa, Yasunari Miyazaki","doi":"10.12659/AJCR.950221","DOIUrl":"10.12659/AJCR.950221","url":null,"abstract":"<p><p>BACKGROUND Persistent COVID-19 in immunocompromised patients, such as those with B-cell depletion or hematologic malignancies, is an important clinical challenge. Clinically, cases that do not respond to guideline-based antivirals, such as molnupiravir, remdesivir, and nirmatrelvir/ritonavir, are occasionally encountered, but effective therapeutic alternatives remain scarce. We report a case of persistent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection unresponsive to guideline-based antivirals, for which the traditional Japanese herbal medicine Mao-to (Ma-huang-tang) led to clinical improvement. CASE REPORT A 62-year-old man, who underwent treatment for follicular lymphoma with anti-cluster of differentiation-20 antibody and achieved remission, developed persistent SARS-CoV-2 infection. Despite 1 course of molnupiravir and nirmatrelvir/ritonavir each and multiple courses of remdesivir and corticosteroids each, SARS-CoV-2 infection persisted for over 2 months. Following these treatments, the SARS-CoV-2 polymerase chain reaction cycle threshold (Ct) value was 27.6, indicating active COVID-19. Given the lack of further treatment options and clinical stability, Mao-to (Ma-huang-tang), a Japanese herbal medicine (\"Kampo\"), was then administered as a commercially available extract granule (2.5 g, 3 times daily) for 14 days. The SARS-CoV-2 polymerase Ct value improved to 41, suggesting a marked reduction in viral load, with improved clinical symptoms. CONCLUSIONS Mao-to may offer a cost-effective adjunctive option for persistent COVID-19 in immunocompromised patients who fail to respond to conventional therapies. In addition, 14 days of Mao-to treatment cost approximately 1200 JPY (USD $8), significantly less than extended courses of standard antivirals. This case suggests the potential utility of traditional herbal medicine in managing persistent SARS-CoV-2 infections when conventional therapies fail.</p>","PeriodicalId":39064,"journal":{"name":"American Journal of Case Reports","volume":"27 ","pages":"e950221"},"PeriodicalIF":0.7,"publicationDate":"2026-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12817605/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145946533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BACKGROUND Tardive dyskinesia is an iatrogenic syndrome that can include dystonia, akathisia, facial tics, chorea, and other abnormal involuntary movements. Tardive dyskinesia follows antipsychotic medication and results from the antagonism of dopamine receptors. This report describes a 40-year-old woman with schizophrenia treated with the long-acting antipsychotic paliperidone palmitate, with persistent tardive dyskinesia, requiring long-term management. CASE REPORT A 40-year-old woman with schizophrenia was administered long-acting paliperidone palmitate for 1 month in April 2017 and then switched to long-acting paliperidone palmitate for 3 months starting in October 2017. After 3 months of long-acting injection exposure (April 2018), she developed sustained cervical posturing and mask-like facies. Dose reduction to 350 mg was ineffective; the long-acting injection was stopped in June 2019, and aripiprazole 10 mg/day was started. Adjuncts (trihexyphenidyl, amantadine, and intermittent benzodiazepines) provided only limited benefit. Clozapine was started in December 2019 and titrated, with gradual, incomplete improvement. On readmission in May 2024, Neurology diagnosed tardive dyskinesia, particularly tardive dystonia. Over 6 years without vesicular monoamine transporter 2 (VMAT-2) inhibitors, her dystonia lessened but persisted, and she was discharged on clozapine and fluvoxamine. CONCLUSIONS Tardive dystonia can follow exposure to long-acting injectable paliperidone and may be prolonged yet partly reversible despite discontinuation. Given therapeutic limits, variable prognosis, and the 3-month formulation's extended pharmacokinetics, clinicians should maintain high suspicion, minimize dopamine-receptor-blocking exposure, and individualize care, considering timely VMAT-2 inhibitors or clozapine, plus structured long-term motor monitoring and shared decision-making. This report highlights the presentation of tardive dyskinesia as a complication of antipsychotic medication and the approach to management of this iatrogenic syndrome.
{"title":"Prolonged Tardive Dyskinesia Induced by Long-Acting Paliperidone Palmitate in Schizophrenia: A Case Report.","authors":"Yu-Ming Chen, Shangwen Chang","doi":"10.12659/AJCR.949867","DOIUrl":"10.12659/AJCR.949867","url":null,"abstract":"<p><p>BACKGROUND Tardive dyskinesia is an iatrogenic syndrome that can include dystonia, akathisia, facial tics, chorea, and other abnormal involuntary movements. Tardive dyskinesia follows antipsychotic medication and results from the antagonism of dopamine receptors. This report describes a 40-year-old woman with schizophrenia treated with the long-acting antipsychotic paliperidone palmitate, with persistent tardive dyskinesia, requiring long-term management. CASE REPORT A 40-year-old woman with schizophrenia was administered long-acting paliperidone palmitate for 1 month in April 2017 and then switched to long-acting paliperidone palmitate for 3 months starting in October 2017. After 3 months of long-acting injection exposure (April 2018), she developed sustained cervical posturing and mask-like facies. Dose reduction to 350 mg was ineffective; the long-acting injection was stopped in June 2019, and aripiprazole 10 mg/day was started. Adjuncts (trihexyphenidyl, amantadine, and intermittent benzodiazepines) provided only limited benefit. Clozapine was started in December 2019 and titrated, with gradual, incomplete improvement. On readmission in May 2024, Neurology diagnosed tardive dyskinesia, particularly tardive dystonia. Over 6 years without vesicular monoamine transporter 2 (VMAT-2) inhibitors, her dystonia lessened but persisted, and she was discharged on clozapine and fluvoxamine. CONCLUSIONS Tardive dystonia can follow exposure to long-acting injectable paliperidone and may be prolonged yet partly reversible despite discontinuation. Given therapeutic limits, variable prognosis, and the 3-month formulation's extended pharmacokinetics, clinicians should maintain high suspicion, minimize dopamine-receptor-blocking exposure, and individualize care, considering timely VMAT-2 inhibitors or clozapine, plus structured long-term motor monitoring and shared decision-making. This report highlights the presentation of tardive dyskinesia as a complication of antipsychotic medication and the approach to management of this iatrogenic syndrome.</p>","PeriodicalId":39064,"journal":{"name":"American Journal of Case Reports","volume":"27 ","pages":"e949867"},"PeriodicalIF":0.7,"publicationDate":"2026-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12814749/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145949398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BACKGROUND Tracheogastric conduit fistula (TGCF) is a rare but life-threatening complication of esophagectomy, particularly in high-risk patients with comorbidities or prior chemoradiotherapy. It typically develops in the setting of anastomotic leakage, ischemia, or infection. There is no standardized treatment, and outcomes vary depending on timing and surgical approach. We report a delayed TGCF after thoracolaparoscopic esophagectomy and describe the operative technique and key perioperative considerations. CASE REPORT A 78-year-old man with diabetes, hypertension, and a heavy smoking history underwent thoracolaparoscopic esophagectomy for Siewert type I adenocarcinoma following neoadjuvant chemoradiotherapy. On postoperative day 54, persistent coughing prompted imaging and endoscopy, which revealed a tracheogastric fistula between the gastric conduit and posterior membranous trachea. Surgical repair was performed via right thoracotomy, involving debridement, closure of the gastric and tracheal defects, and interposition of a vascularized intercostal muscle flap. Reinforcement with fibrin sealant and a bovine pericardial patch was applied. Initial bronchoscopy confirmed airtight repair. However, the patient later developed recurrent pneumonia and septic shock, ultimately dying to multiorgan failure on postoperative day 108. CONCLUSIONS This case illustrates the complex management of TGCF and reinforces the value of early recognition and aggressive surgical intervention. Despite the fatal outcome, the absence of fistula recurrence confirmed the technical success and offers insight for managing similar high-risk cases. Intercostal muscle flap remains a reliable option for fistula closure in irradiated and infected fields. Meticulous surgical planning and perioperative management are essential for optimizing outcomes in this rare complication.
{"title":"Technical Approach to Repair of Tracheogastric Conduit Fistula Following Minimally Invasive Esophagectomy: A Case Report.","authors":"Wongsakorn Chaochankit, Srila Samphao, Voravit Chittithavorn, Chutida Sungworawongpana","doi":"10.12659/AJCR.950499","DOIUrl":"10.12659/AJCR.950499","url":null,"abstract":"<p><p>BACKGROUND Tracheogastric conduit fistula (TGCF) is a rare but life-threatening complication of esophagectomy, particularly in high-risk patients with comorbidities or prior chemoradiotherapy. It typically develops in the setting of anastomotic leakage, ischemia, or infection. There is no standardized treatment, and outcomes vary depending on timing and surgical approach. We report a delayed TGCF after thoracolaparoscopic esophagectomy and describe the operative technique and key perioperative considerations. CASE REPORT A 78-year-old man with diabetes, hypertension, and a heavy smoking history underwent thoracolaparoscopic esophagectomy for Siewert type I adenocarcinoma following neoadjuvant chemoradiotherapy. On postoperative day 54, persistent coughing prompted imaging and endoscopy, which revealed a tracheogastric fistula between the gastric conduit and posterior membranous trachea. Surgical repair was performed via right thoracotomy, involving debridement, closure of the gastric and tracheal defects, and interposition of a vascularized intercostal muscle flap. Reinforcement with fibrin sealant and a bovine pericardial patch was applied. Initial bronchoscopy confirmed airtight repair. However, the patient later developed recurrent pneumonia and septic shock, ultimately dying to multiorgan failure on postoperative day 108. CONCLUSIONS This case illustrates the complex management of TGCF and reinforces the value of early recognition and aggressive surgical intervention. Despite the fatal outcome, the absence of fistula recurrence confirmed the technical success and offers insight for managing similar high-risk cases. Intercostal muscle flap remains a reliable option for fistula closure in irradiated and infected fields. Meticulous surgical planning and perioperative management are essential for optimizing outcomes in this rare complication.</p>","PeriodicalId":39064,"journal":{"name":"American Journal of Case Reports","volume":"27 ","pages":"e950499"},"PeriodicalIF":0.7,"publicationDate":"2026-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12814743/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145935534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}